Imperial College London


Faculty of MedicineSchool of Public Health

Professor of Cardiovascular Epidemiology



+44 (0)7866 365 776john.chambers




172Medical SchoolSt Mary's Campus






My research focuses on the investigation of genetic and environmental mechanisms underlying obesity, diabetes, cardiovascular disease and related phenotypic disturbances in Indian Asians. In the last ten years I have worked closely with Professor JS Kooner (NHLI), Professor Paul Elliott (SPH), Professor James Scott (NHLI) and others, to establish the London Life Sciences Population (LOLIPOP) study, one of the largest cohort studies of Indian Asians world-wide. Our recent research efforts have capitalised on this unique population cohort, to provide new insight into the mechanisms underlying obesity, diabetes, cardiovascular disease and other human phenotypes. Key outputs include: 

  • Identification of MLXIPL as a key determinant of plasma triglyceride levels through its function as a co-ordinator of transcriptional regulation of enzymes that channel glycolytic end-products into lipogenesis and energy storage. (Kooner et al. Nature Genetic 2008)
  • Showed that common genetic variants near hypothalamic receptor MC4R are associated with central obesity and insulin resistance. Risk-allele frequencies are higher amongst Indian Asians than Europeans, suggesting a possible genetic mechanism contributing to the increased burden of central adiposity and insulin resistance in Asians. (Chambers et al. Nature Genetics 2008)
  • Demonstrated novel association of common genetic variants in TMPRSS6 with haemoglobin levels amongst people of both European and Indian Asian ancestry, most likely mediated through alteration of protease function, and hepcidin mediated control of iron homeostasis. Our findings could provide new insight into the genetic factors influencing anaemia and related blood disorders in man (Chambers et al. Nature Genetics 2009).
  • Showed for the first time that that genetic variants in SCN10A influence cardiac conduction, and that genetic variation at SCN10A locus is a novel susceptibility factor for heart block and serious ventricular arrhythmia in man (Chambers et al. Nature Genetics 2010).
  • Used genetic association, and the concept of Mendelian randomisation, to address the key question of whether CRP is causally linked with atherosclerosis or simply a marker of underlying inflammatory disturbances in atherosclerosis ( al. JAMA 2009)
  • Identifiedfour genetic loci influencing kidney function and risk of chronic kidney disease. (Chambers et al. Nature Genetics 2010).



Wain LV, Evangelou E, Chambers JC, et al., Novel blood pressure locus and gene discovery using GWAS and expression datasets from blood and the kidney., Hypertension, ISSN:1524-4563

Boger CA, Gorski M, McMahon GM, et al., 2017, NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality, Journal of the American Society of Nephrology, Vol:28, ISSN:1046-6673, Pages:2311-2321

Graff M, Scott RA, Justice AE, et al., 2017, Genome-wide physical activity interactions in adiposity. A meta-analysis of 200,452 adults, Plos Genetics, Vol:13, ISSN:1553-7404

Heiss JA, Breitling LP, Lehne B, et al., 2017, Training a model for estimating leukocyte composition using whole-blood DNA methylation and cell counts as reference, Epigenomics, Vol:9, ISSN:1750-1911, Pages:13-20

Justice AE, Winkler TW, Feitosa MF, et al., 2017, Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits, Nature Communications, Vol:8, ISSN:2041-1723

More Publications